Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Gloucester Street Capital
AddedFeb 18, 2024
UpdatedJun 18, 2026
Gloucester Street Capital

Gloucester Street Capital

Seed

Gloucester Street Capital: A New York-based producer of pharmaceutical-grade medical cannabis since 2014.

HQ
Purchase, NY, US
Founded
2014
Overview
Compare
Fundraising
Employees

Gloucester Street Capital, founded in 2014 and headquartered in Purchase, New York, focuses on producing pharmaceutical-grade medical cannabis. The company aims to integrate proprietary manufacturing processes, compassionate patient care delivery systems, and strategic go-to-market approaches to enhance the medical cannabis industry.

The company has made significant strides in the medical cannabis sector, leveraging its innovative processes and patient-centric care models. Gloucester Street Capital's impact is marked by its commitment to quality and patient well-being, establishing itself as a key player in the pharmaceutical-grade cannabis market.

Gloucester Street Capital - Similar Companies

Natural State Medical Group logo

Natural State Medical Group

Maryland Cultivation & Processing logo

Maryland Cultivation & Processing

PharmaCann logo

PharmaCann

pharmacann.com

Groundworks Industries logo

Groundworks Industries

gw-ind.com

Harvest & Bloom logo

Harvest & Bloom

Revolution Global logo

Revolution Global

TheraTrue logo

TheraTrue

theratrue.com

CuraleafHoldnc. logo

CuraleafHoldnc.

curaleaf.com

Cresco Labs logo

Cresco Labs

crescolabs.com

Omgreens logo

Omgreens

omgreens.com

Glacier Cannabis logo

Glacier Cannabis

glaciercanna.com

WGD Capital logo

WGD Capital

wgdcapital.com

KushStack logo

KushStack

Grassp Health logo

Grassp Health

Green Thumb Industries logo

Green Thumb Industries

gtigrows.com

Gloucester Street Capital - Quick Facts

Who are Gloucester Street Capital's competitors?

Companies similar to Gloucester Street Capital include Natural State Medical Group, Maryland Cultivation & Processing, PharmaCann and Groundworks Industries.

When was Gloucester Street Capital founded?

Gloucester Street Capital was founded in 2014.

Where is Gloucester Street Capital's headquarters located?

Gloucester Street Capital's headquarters is located in Purchase, NY, US.

When was Gloucester Street Capital's last funding round?

Gloucester Street Capital's most recent funding round was for $500k (USD) in February 2015.

How much has Gloucester Street Capital raised to-date?

As of Feb 9, 2015, Gloucester Street Capital has raised a total of $500k (USD).

How many employees does Gloucester Street Capital have?

Gloucester Street Capital has 30 employees as of Feb 5, 2024.

Gloucester Street Capital - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Medical Cannabis
Tags
  • SaaS
NAICS
  • 459900Other Miscellaneous Retailers
  • 459990All Other Miscellaneous Retailers
  • 459991Tobacco, Electronic Cigarette, and Other Smoking Supplies Retailers
  • 450000Retail Trade
  • 459000Sporting Goods, Hobby, Musical Instrument, Book, and Miscellaneous Retailers
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 1 more industry code
NAICS
  • 620000Health Care and Social Assistance